In 2012, Illumina broadened the scope of the Agricultural Greater Good Initiative through engagement with the Bill & Melinda Gates Foundation and Dow AgroSciences, as well as with the Feed the Future Initiative of the United States Agency for International Development (USAID).“We’re excited about the opportunity to connect advances in sequencing technologies with the needs of millions of families farming small plots of land in sub-Saharan Africa and South Asia,” said Katherine Kahn, Senior Program Officer at the Bill & Melinda Gates Foundation. “Increasing the productivity and resilience of staple crops including cassava and legumes is key to helping small farmers lift themselves out of poverty.” “Through science, Dow AgroSciences is working to serve the needs of the growing world,” said Gordon Slack, Dow AgroSciences Global Leader, Finance and Public Affairs. “The need for novel solutions to address food insecurity in Africa and other locations is of paramount importance to Dow AgroSciences employees and the agriculture industry as a whole. We are honored to play a part in this vital work.” Illumina’s Agricultural Greater Good Initiative, launched in 2011, helps to spur critically needed research that will increase the sustainability, productivity and nutritional density of agriculturally important crop and livestock species. Grant recipients receive donations of Illumina reagents to support their projects. For more information about the Illumina Agricultural Greater Good Initiative, please visit: www.illumina.com/agrigood. About Illumina Illumina ( www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare. About ICRISAT The International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT) is a non-profit, non-political organization that conducts agricultural research for development in Asia and sub-Saharan Africa with a wide array of partners throughout the world. Covering 6.5 million square kilometers of land in 55 countries, the semi-arid tropics have over 2 billion people, and 644 million of these are the poorest of the poor. ICRISAT and its partners help empower these poor people to overcome poverty, hunger and a degraded environment through better agriculture. ICRISAT is headquartered in Patancheru near Hyderabad, Andhra Pradesh, India, with two regional hubs and five country offices in sub-Saharan Africa. It is a member of the CGIAR Consortium. CGIAR is a global agriculture research partnership for a food secure future. Its science is carried out by the 15 research centers who are members of the CGIAR Consortium in collaboration with hundreds of partner organizations. For more information, please visit ICRISAT ( www.icrisat.org) and CGIAR ( www.cgiar.org). About the BecA-ILRI Hub The Biosciences eastern and central Africa-International Livestock Research Institute (BecA‐ILRI) Hub is a world-class agricultural research and biosciences facility located at and managed by ILRI in Nairobi, Kenya. It provides support to African and international scientists conducting research on African agricultural challenges and acts as a focal point for learning, interaction and strategic research – enabling collaborations in the scientific community to benefit African farmers and markets within the region. The Hub was established as part of an African Union/New Partnership for Africa’s Development (NEPAD) African Biosciences Initiative, which employs modern biotechnology to improve agriculture, livelihoods and food security in eastern and central Africa . For more information, please visit http://hub.africabiosciences.org and www.ilri.org. Forward-Looking Statements This release may contain forward looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those in any forward-looking statements are detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We do not intend to update any forward-looking statements after the date of this release.